January 2020 FDA Recall Drug by Ncs Healthcare Of Kentucky Inc
D-0850-2020 - Failed Impurities/Degradation Specification
This Class II drug recall was voluntarily initiated by Ncs Healthcare Of Kentucky Inc on January 28, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specification. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0850-2020
Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
01-28-2020
02-26-2020
6929 blister cards
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
NCS Healthcare of Kentucky Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the USA.
02-19-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.
Batch or Lot Expiration Information
Lot# : 8170-9004, Exp 01/2020